GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/TEDDY Study - Dietary Supplements, reduces Celiac Disease Risk
73

TEDDY Study - Dietary Supplements, reduces Celiac Disease Risk

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated April 1, 2025

The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520 children with HLA-DQ2 or DQ8 haplotypes from birth to age 13, analyzing dietary patterns and their impact on celiac disease development. A key finding was that higher dietary fiber intake during infancy (ages 6 months to 2 years) significantly reduced the risk of developing celiac disease later in life, independent of gluten consumption or specific food sources. This protective effect was limited to early childhood, as fiber intake after age 3 showed no significant association with celiac disease risk.

The study highlighted the importance of dietary fiber in enhancing gut barrier integrity, supporting beneficial microbial colonization, and modulating immune tolerance during critical early-life windows. While maternal fiber intake during pregnancy may also play a role, the infant’s diet emerged as the dominant factor in reducing celiac risk. Foods rich in plant-based fiber, such as oats, legumes, and root vegetables, were associated with lower celiac autoimmunity.

Dietary supplements were not explicitly studied as part of the TEDDY research, but the findings suggest that promoting fiber-rich diets in infancy could serve as a non-invasive preventive strategy for children genetically at risk. Future research could explore whether specific fiber supplements or prebiotics might replicate these protective effects, though current evidence emphasizes whole food sources. Additionally, further mechanistic studies are needed to confirm causality and understand fiber-driven microbial and immune interactions in preventing celiac disease.

Related Q&A

74

Microbiome-Directed Therapy for Malnutrition

Microbiome-directed therapy for malnutrition represents a groundbreaking approach to addressing childhood undernutrition by targeting the gut microbiome, a critical determinant of health and growth outcomes. Traditional treatments, such...

75

Imaging findings of IBS patients

Imaging studies have revealed several significant findings in patients with irritable bowel syndrome (IBS). These findings span both abdominal and brain imaging, shedding light on the structural and...

76

Microbiota and IBD-C

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of IBS characterized by chronic constipation, abdominal discomfort, and altered bowel habits. The study you referenced explored the relationship between...

77

Risk of IBD in IBS patients

Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study...

78

Healthy Lifestyle and Bowel Disease Risk

The study conducted by researchers at the University of Oslo in collaboration with the Song Lab at Harvard T.H. Chan School of Public Health provides compelling evidence that...

79

ACTION Trial

The ACTION trial was a significant clinical study designed to evaluate the efficacy and safety of acupuncture in treating diarrhea-predominant irritable bowel syndrome (IBS-D). Below is a detailed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer